Innovative MedTech Inc.
IMTH · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $2 | $2 | $1 |
| % Growth | -100% | 5.8% | 32.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $2 | $2 | $1 |
| % Margin | – | 96.4% | 96.7% | 94.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $6 | $2 | $20 |
| SG&A Expenses | $1 | $6 | $2 | $20 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2 | -$0 | $3 | $0 |
| Operating Expenses | $3 | $6 | $5 | $20 |
| Operating Income | -$3 | -$4 | -$4 | -$18 |
| % Margin | – | -234.2% | -210.1% | -1,406.6% |
| Other Income/Exp. Net | $4 | -$4 | -$0 | $0 |
| Pre-Tax Income | $1 | -$8 | -$4 | -$18 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | -$8 | -$4 | -$18 |
| % Margin | – | -435% | -211.5% | -1,391.2% |
| EPS | 0.03 | -0.33 | -0.17 | -1.09 |
| % Growth | 109.1% | -94.1% | 84.4% | – |
| EPS Diluted | 0.03 | -0.33 | -0.17 | -1.09 |
| Weighted Avg Shares Out | 41 | 24 | 21 | 17 |
| Weighted Avg Shares Out Dil | 41 | 24 | 21 | 17 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | -$0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$3 | -$8 | -$3 | -$18 |
| % Margin | – | -420.7% | -195.3% | -1,371.1% |